Inactive Instrument

Teva Pharmaceutical Industries Limited Share Price TEL AVIV STOCK EXCHANGE

Equities

IL0006290147

Pharmaceuticals

Financials

Sales 2024 * 15.95B 59.1B 1,256B Sales 2025 * 16.52B 61.2B 1,301B Capitalization 18.45B 68.35B 1,453B
Net income 2024 * 820M 3.04B 64.57B Net income 2025 * 1.39B 5.14B 109B EV / Sales 2024 * 2.09 x
Net Debt 2024 * 14.93B 55.29B 1,175B Net Debt 2025 * 12.41B 45.97B 977B EV / Sales 2025 * 1.87 x
P/E ratio 2024 *
17.3 x
P/E ratio 2025 *
12.1 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 89.71%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 55 31/12/22
Director of Finance/CFO 51 21/12/19
Chief Tech/Sci/R&D Officer - 31/07/22
Members of the board TitleAgeSince
Director/Board Member 77 31/08/15
Director/Board Member 59 08/06/20
Chairman 76 31/12/14
More insiders
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Calendar
More about the company